EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study on the value of second‐generation sequencing technology in the clinical diagnosis of osteoarticular brucellosis

Xiaowei Yao, Guisong Zhao, Lianbo Wang, Chenguang Jia iD

Journal of Orthopaedic Research · 2024

DOI: 10.1002/jor.25867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2024. Verfasst von Xiaowei Yao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Chest Hospital of Hebei Province, Shijiazhuang, China. Hauptthemen laut MEDLINE: Brucellosis, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2019 Medical Science Research Project in Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To assess the value of next‐generation sequencing (NGS) technology in the diagnosis of osteoarticular brucellosis pathogenesis. Fifty eight patients admitted to the Department of Orthopaedics, Hebei Provincial Chest Hospital from January 2021 to January 2023 were retrospectively analyzed, and the patients were classified into 48 cases in the osteoarticular brucellosis group and 10 cases in the nonosteoarticular brucellosis group according to the final clinical diagnosis. All patients underwent serum agglutination test (SAT), CT‐guided puncture or surgical sampling of lesions for bacteriological culture and NGS after admission. The diagnostic efficacy of these three methods for osteoarticular brucellosis was compared using the final clinical diagnosis as the reference standard. Among the 58 patients with suspected osteoarticular brucellosis, 40 cases (68.97%) were positive by NGS, 33 cases (56.89%) by SAT and 10 cases (17.24%) by culture, and the differences were statistically significant ( p < 0.05). Using the final clinical diagnosis as a criterion, the sensitivity of NGS, SAT, and culture for the detection of osteoarticular brucellosis was 83.33%, 62.50%, and 20.83%, respectively, the specificity was 100.00%, 70.00%, and 100.00%, the diagnostic accuracy was 86.20%, 63.79%, and 34.49%, and the κ values were 0.799, 0.590, and 0.504, respectively. NGS has a high pathogen detection rate and sensitivity in the pathogenetic diagnosis of patients with osteoarticular brucellosis and can provide clinical guidance for the diagnosis and management of patients with osteoarticular brucellosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrucellosisHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedFemaleRetrospective StudiesAdultAgedAgglutination TestsSensitivity and Specificity

Stichwörter der Autor:innen

brucellosisdiagnostic techniquesgenomic II sequencingosteoarthritis

Autor:innen und Institutionen

  • Department of Orthopedics, The Chest Hospital of Hebei Province, Shijiazhuang, China.

ORCID-Profile: Chenguang Jia

Förderung

  • 2019 Medical Science Research Project in Hebei Province

Zitieren

APA

Yao, X., Zhao, G., Wang, L., & Jia, C. (2024). Study on the value of second‐generation sequencing technology in the clinical diagnosis of osteoarticular brucellosis. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.25867

Vancouver

Yao X, Zhao G, Wang L, Jia C. Study on the value of second‐generation sequencing technology in the clinical diagnosis of osteoarticular brucellosis. Journal of Orthopaedic Research. 2024. doi:10.1002/jor.25867

BibTeX
@article{Yao2024,
  author = {Yao, Xiaowei and Zhao, Guisong and Wang, Lianbo and Jia, Chenguang},
  title = {Study on the value of second‐generation sequencing technology in the clinical diagnosis of osteoarticular brucellosis},
  journal = {Journal of Orthopaedic Research},
  year = {2024},
  doi = {10.1002/jor.25867}
}
Kostenlos starten →